The Vienna based biotech company APEIRON Biologics AG supports the clinical development of an immune therapy against high-risk neuroblastoma in paediatric patients that is being conducted by the CCRI and the European Neuroblastoma Research Network…
Press conference: Oncology Alliance: Apeiron and CCRI join forces to battle neuroblastoma in children
"KLIF” Project: Visit of Prof. Dr. Karlheinz Töchterle, Federal Minister of Science and Research, at the CCRI
Photo Copyright: HBF / Regina Aigner (from left to right) DI Dagmar Denk, Federal Minister Töchterle, Prof. Gadner, MD, Assoc. Prof. Ladenstein, MD, Prof. Kovar, PhD Projects submitted for the "KLIF" call must involve…